Vincent Serra

USPTO Granted Patents = 7 (Patent Applications = 3)

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 1.1

ph-index = 1

Forward Citations = 7(Granted Patents)

Company Filing History:

Institut National De La Sante Et De La Recherche Medicale

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12059457 - Immunogenic product comprising IL-4 and/or IL-13 for treating disorders associated with aberrant IL-4 and/or IL 13 expression or activity (2024-08-13),

2. 10870671 - Method of preparation of alpha galactosyl ceramides compounds (2020-12-22),

3. 9220767 - Vaccine composition for use against influenza (2015-12-29),

4. 8916164 - Methods of enhancing adjuvaticity of vaccine compositions (2014-12-23),

5. 8642565 - Increase of immune response and targeting by antigens and/or drug linkage (2014-02-04),

6. 8211861 - Compositions for and methods of enhancing the immune response to antigens (2012-07-03),

7. 8207135 - Compositions for and methods of enhancing the immune response to antigens (2012-06-26),

Title: Vincent Serra: Innovator in Immunogenic Products

Introduction

Vincent Serra is a notable inventor based in Bondoufle, France. He has made significant contributions to the field of immunology, holding a total of seven patents. His work focuses on developing innovative solutions for treating disorders associated with aberrant cytokine expression.

Latest Patents

Among his latest patents is an immunogenic product comprising IL-4 and/or IL-13 for treating disorders linked to abnormal IL-4 and/or IL-13 activity. This product includes a cytokine conjugated with a carrier protein, specifically CRM. Additionally, he has developed a method for manufacturing this immunogenic product, which is aimed at treating inflammatory disorders associated with aberrant IL-4 and/or IL-13 expression. Another significant patent involves a method for preparing alpha-galactosyl ceramide compounds, which includes a glycosylation step of specific compounds.

Career Highlights

Vincent Serra has worked with several companies throughout his career, including Wittycell and Abivax. His experience in these organizations has contributed to his expertise in the field of immunology and patent development.

Collaborations

Vincent has collaborated with notable coworkers such as Géraldine Grouard-Vogel and Eva Conde García. Their joint efforts have further advanced the research and development of immunogenic products.

Conclusion

Vincent Serra's innovative work in immunogenic products and his extensive patent portfolio highlight his significant contributions to the field of immunology. His dedication to developing therapeutic solutions continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.